INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGXPRNewsWire • Thursday
argenx to Acquire Unnatural Products, Inc., Adding Peptide Discovery Engine to Broaden Immunology CapabilitiesGlobeNewsWire • Monday
Unnatural Products to be Acquired by argenx for up to $1.15 Billion to Advance Next-Generation MedicinesGlobeNewsWire • Monday
argenx Presents Phase 3 ALKIVIA Data at ACR Convergence 2026 Showing Rapid and Sustained Improvement with Efgartigimod in Autoimmune MyositisGlobeNewsWire • 11/07/26
Argenx Slumps On Mixed Third Quarter, Surprise Vyvgart Testing PlansInvestors Business Daily • 10/22/26
argenx to Report Third Quarter 2026 Financial Results and Business Update on October 22, 2026GlobeNewsWire • 10/15/26
ARGX Investors with $100,000 in Losses Have Opportunity to Join argenx SE Fraud Investigation with SBS LawBusiness Wire • 10/12/26
argenx Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into argenx (ARGX)PRNewsWire • 10/08/26
argenx shares drop after trial of Vyvgart in Sjögren's disease is haltedProactive Investors • 10/08/26
Former Highflier Argenx Plummets On A Surprise Setback In Sjogren'sInvestors Business Daily • 10/08/26
Argenx, Caribou Biosciences And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionBenzinga • 10/08/26